Zeng Tingting, Sun Kan, Mai Lifang, Hong Xiaosi, He Xiaodan, Lin Weijie, Chen Sifan, Yan Li
Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou, China.
Diabetes. 2025 Apr 1;74(4):596-610. doi: 10.2337/db24-0701.
An understanding of cell interactions is needed to identify therapeutic targets for diabetic cutaneous ulcers. We explored extracellular vesicles after treatment with advanced glycation end products (AGEs-EVs) derived from macrophages that can suppress diabetic cutaneous wound healing. We found that a novel miRNA enriched in AGEs-EVs (miR-ERIA) suppresses the migration and tube formation of vascular endothelial cells by targeting helicase with zinc finger 2. miR-ERIA offers a potential therapeutic target for diabetic cutaneous ulcers.
为了确定糖尿病皮肤溃疡的治疗靶点,需要了解细胞间的相互作用。我们研究了巨噬细胞衍生的晚期糖基化终产物(AGEs-EVs)处理后的细胞外囊泡,这种细胞外囊泡会抑制糖尿病皮肤伤口愈合。我们发现,一种富含于AGEs-EVs中的新型微小RNA(miR-ERIA)通过靶向锌指解旋酶2来抑制血管内皮细胞的迁移和管腔形成。miR-ERIA为糖尿病皮肤溃疡提供了一个潜在的治疗靶点。